• Skandi Network starts with members in 25 European countries
• Extension planned up to 36 member countries by end of 2025
• Operational coverage in all EU-countries right from the start
• Connecting existing domestic networks into the first GDP-certified temperature-controlled international distribution network 100 % dedicated to life science products for parcels and pallets groupage overland Europe.
• Tailormade digital collaborative platform for managing shipments and real time end-to-end visibility to shippers and receivers
• Combination of national and international shipments will lead to higher consolidation and lower emissions – members committed to reduce CO2 emissions in line with the Paris Climate Agreement

Brussels, 17 December 2022 –  Seven companies specialized in healthcare logistics, including PHSE a leading company in pharmaceutical logistics, have entered into the alliance Skandi Network,  the first international GDP-compliant temperature-controlled distribution network dedicated to life science goods. “More and more companies in the healthcare industry are looking for best-in-class international transport and distribution solutions according to the rules of EU-Good Distribution Practice (GDP)”, says Rudy Smets, Managing Director of the newly founded network. “Skandi Network combines the capacities and the know-how of leading European specialists who all have a strong expertise in temperature-controlled transport and distribution of life science products. And we put all this into one European network for the mutual benefit of customers, patients, shippers, transport companies and the environment.” According to Morten Studsgaard, CEO of BHS Logistics, the major advantage for shippers is that they can “access experts for GDP temperature control to manage cross-border shipments easily and securely in a cost-efficient way.”. This will lead to higher consolidation and therefore is an ideal means to align quality, costs and reduce emissions.

Paul Wilkinson, President of Movianto UK, points out that a main asset of Skandi Network is “a unique digital collaborative information platform system called CIPS – Collaborative Information Platform System, developed for the network.” CIPS’s   task is to integrate all the data from the members’ own IT systems and make it accessible through one common frontend. “If you take a shipment from Denmark to Portugal for example, then with CIPS it will be possible for the shipper, the consignee and for all the partners to have a complete temperature curve of the shipment directly after the delivery scan.” The information will be given on a shipment as well as on a parcel level. Therefore, CIPS will make it easy for new members to connect to the platform as they can go on using their existing software and hardware. Furthermore, the information about where a shipment is, where it should go to and what the temperature is, facilitates multi country shipment consolidation in one of the 10 strategic regional consolidation platforms of Skandi Network. “And last but not least”, Wilkinson adds, the tool gives clients and end customers access to this information in real time providing full transparency”.

Another main differentiator in comparison to existing transport networks is the 100 % focus of Skandi Network on life science products. This includes the distribution of pharmaceuticals, biomedicals, diagnostics, medical devices, and vaccines to virtually all hospitals, pharmacies, pharmaceutical wholesalers, care facilities, doctors, veterinarians, laboratories, home patients, pharmaceutical field service organizations and sales representatives. Most of these products are temperature-sensitive and require active temperature-controlled environments like 2-8 °C, 15-25 °C or even -25°C. Focus will be on parcel and 1 up to max 5 pallet shipments per consignment.

Members from UK to Turkey, from Poland to Portugal

The members of the network and the respective countries in which they will provide service are: Arra Group (Poland), BHS Logistics (Denmark, Sweden, Norway, Finland, Estonia, Latvia, Lithuania), BL Turkey Biopharma Logistics (Turkey),  Eurotranspharma (France, Belgium, the Netherlands, Luxemburg, Spain, Czech Republic, Slovakia and also Germany, Austria and Slovenia via its existing local partner), Movianto (England, Scotland, Wales, Northern Ireland), PHSE (Italy), Rangel Logistics Solutions (Portugal). This means that members of SKANDI Network cover 25 countries right from the start. The aim of SKANDI Network is to have members covering 36 countries by 2025 latest. In total the network members have more than 4.000 employees, operate 4.780 temperature-controlled vehicles, 10 strategic regional consolidation platforms, 165 temperature controlled depots and transport 14.750.000 temperature controlled shipments per year.

On a worldwide level, Life Logistics Network has joined SKANDI Network as a “Supporting Partner” of the network. The same applies in the opposite direction.  Life Logistics Network is a global network composed of top-class pharmaceutical forwarders around the world who will have access to SKANDI Network.

Sustainability is core to Skandi Network

“One of the strategic topics of SKANDI Network and main reasons to build it is sustainability”, adds Nuno Rangel, CEO of Rangel Logistics Solutions. “If acting alone it is nearly impossible for a logistics service provider to become a trusted and responsible part of the solution in the sustainable transformation of the European life science industry. But in acting together it is possible.” In terms of sustainability Skandi Network has two main objectives and offers two benefits. “Our first objective is to investigate realistic technological solutions for sustainable fuels, vehicles, and refrigeration technologies.” The second objective according to Schachinger is “to design a sustainable roadmap for the environment by aligning partner actions in key areas to help reduce CO2 emissions across the network by 2030, in line with the Paris Climate Agreement, and to reach Zero Emission level in 2050 latest.”  The collaboration in Skandi Network will reduce emissions per shipment because of two facts: first is higher consolidation and drop factors in long haul and on the last mile because of the combination of national and international shipments. Secondly, the active temperature-controlled transport eliminates the need for temperature-controlled packaging (TCP) solutions and passive packaging solutions, which leads to higher transport weights, higher return transports and/or higher waste and disposal cost.

PHSE Group

PHSE is today a market leader in the transport and distribution of hospital and home temperature controlled pharmaceutical products, unique in Italy for the type of services offered and expertise. PHSE is one of the few international providers specialized exclusively in the biopharma segment and in the management of worldwide shipments (by air, land and sea) of pharmaceutical products and clinical trials in support of clinical research, at any temperature required. Founded in 2002, in almost 20 years of history, the company has developed a high level of specialization conquering more than 50% of the Italian 2-8°C distribution market. The co-investment agreement, reached in December 2019 between entrepreneur Eddy De Vita and NB Aurora to take over control of PHSE, marked an important step in PHSE business development and brought managerial expertise and new financial resources to accelerate the company’s growth path. With 400 employees and proprietary fleet of more than 370 new generation vehicles, PHSE now has 21 branches with GDP warehouses, as well as its subsidiary Innoplus, a leading manufacturer and distributor of validated packaging solutions and intelligent devices capable of tracking any shipment data. Over the years, PHSE has received CEIV Pharma certifications from the International Air Transport Association (IATA), ISO 9001-2015 (Quality), ISO 14001 (Environment), TAPA TSR (Safety), GDP and the Authorization to Transport Radioactive Material by Road.

Fonte: SKANDI Network press release